Who owns ISIS Pharmaceuticals?

Key details on ISIS Pharmaceuticals (Ticker: ISIS)

Who owns ISIS Pharmaceuticals?

Is ISIS a good stock to own? Find out who bought ISIS Pharmaceuticals, who sold ISIS Pharmaceuticals (ISIS) stock, and who holds a large position in ISIS Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
FMR 17.55M $681.46M Sept. 30, 2014
ClearBridge Advisors 9.03M $557.79M Dec. 31, 2014
Vanguard 7.27M $448.97M Dec. 31, 2014
BB Biotech AG 5.98M $368.99M Dec. 31, 2014
Waddell & Reed Financial 5.45M $336.51M Dec. 31, 2014
Columbia Wanger Asset Management 5.08M $71.52M Sept. 30, 2012
BlackRock Fund Advisors 4.47M $276.07M Dec. 31, 2014
Artisan Partners Limited Partnership 3.85M $237.86M Dec. 31, 2014
BlackRock Institutional Trust Company, N.A. 2.98M $184.22M Dec. 31, 2014
T. Rowe Price Associates 2.68M $165.36M Dec. 31, 2014
SUSQUEHANNA INTERNATIONAL 2.60M $100.91M Sept. 30, 2014
STATE STREET CORPORATION 2.58M $159.32M Dec. 31, 2014
EQUITEC SPECIALISTS 2.39M $2.39M Dec. 31, 2014
BVF 2.16M $25.94M June 30, 2012
LORD, ABBETT & CO 2.11M $56.65M June 30, 2013
Tocqueville Asset Management 2.10M $35.50M March 31, 2013
OTR - Nominee Name for The State Teachers Retirement Board of Ohio 2.09M $1.94M March 31, 2015
Franklin Resources 2.07M $127.68M Dec. 31, 2014
Gail Mannix 2.02M $80.33M Dec. 31, 2013
Jennison Associates 2.01M $124.15M Dec. 31, 2014